Supplement: Best of CRISPR 2017
Peak CRISPR: On the Cusp of a Biomedical Revolution
Novel Viral Vectors for Gene Therapy
Synthetic Viral Vectors Show Promise for Mitigating Immune Response to Gene Therapy
Literature Review: Defending against Virus, with a Little Help from Microbiome
A Specific Human-Associated Gut Microbe Produced DAT and Rescued Antibiotic-Treated Influenza-Infected Mice
Supplement: Applications of Novel CRISPR Tools
Experts in the Field Speak to the Ways CRISPR Is Used
For full access to this article login to GEN Select now.
Tissue Engineering Revenues Rise
- More than half (52%) of the companies comprising the tissue engineering (TE) and stem cell industries are revenue-generating, compared to about 21% four years ago, according to an analysis published in Tissue Engineering Part B . Of those companies, 31% having commercial products and 21% are service-based; another 30% ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.